CytomX Therapeutics, Inc. Liquidation Value
CTMX
Other
Cash & Equivalents
$12.67M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $12.67M
Total Obligations: -$50.85M
$-38.19M
Per share: $-0.22
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $12.67M
AR: $2.01M
Total Obligations: -$50.85M
$-36.17M
Per share: $-0.21
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $12.67M
AR: $2.01M
Inventory: $0
Total Obligations: -$50.85M
$-36.17M
Per share: $-0.21
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-38.19M | $-0.22 |
| Liquid Liquidation Value | $-36.17M | $-0.21 |
| Operating Liquidation Value | $-36.17M | $-0.21 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $12.67M |
| Accounts Receivable | $2.01M |
| Inventory | N/A |
| Current Liabilities | $46.62M |
| Long-term Debt | N/A |
| Op. Lease Liability | $4.24M |
| Finance Lease | N/A |
| Shares Outstanding | 170.2M |
Explore all 170 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $12.67M | $2.01M | N/A | $1.30M | $46.62M | N/A | $4.24M | N/A |
| 2025-09-30 | $34.19M | $1.63M | N/A | $646,000 | $41.03M | N/A | $5.60M | N/A |
| 2025-06-30 | $49.04M | $1.87M | N/A | $227,000 | $39.22M | N/A | $6.88M | N/A |
| 2025-03-31 | $47.60M | $1.96M | N/A | $276,000 | $50.20M | N/A | $8.15M | N/A |
| 2024-12-31 | $38.05M | $3.10M | N/A | $1.09M | $85.77M | N/A | $9.38M | N/A |
| 2024-09-30 | $40.58M | $3.35M | N/A | $1.42M | $119.23M | N/A | $10.60M | N/A |
| 2024-06-30 | $43.25M | $2.77M | N/A | $611,000 | $142.86M | N/A | $11.75M | N/A |
| 2024-03-31 | $36.19M | $13.18M | N/A | $1.96M | $144.54M | N/A | $12.87M | N/A |
▼ Community Notes